Deals
Activist Elliott Builds Stake in Cinven Takeover Target Synlab
This article is for subscribers only.
Billionaire Paul Singer’s Elliott Investment Management has amassed a position in Synlab AG, signaling the fund may pursue a similar strategy to what it’s done with other German takeover targets.
The activist investment fund holds a 6.5% interest in Synlab as of Nov. 16 through a combination of shares and swaps, according to a filing released Thursday.